Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
ABX 51.91 −0.6% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.73 +9.3% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2% ABX 51.91 −0.6% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.73 +9.3% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2%
Other Routine +

OTC Markets Group Welcomes Charlotte's Web Holdings Inc. to OTCQX

Charlotte's Web Upgrades to OTCQX as BAT Debt Conversion Stabilizes Balance Sheet

By The Northwire Desk — AI Analysis Apr 30, 2026 · 07:00 CWEB · 0.73 CHARLOTTE'S WEB HOLDINGS, INC.
Executive Summary
  • Charlotte's Web Holdings Inc. successfully upgraded its trading tier from the OTCQB Venture Market to the OTCQX Best Market effective April 30, 2026.
  • The company begins trading under the symbol "CWBHF" on the OTCQX.
  • Qualification criteria met include high financial standards, best practice corporate governance, and compliance with securities laws.
  • The upgrade provides U.S. investors access to current financial disclosure and Real-Time Level 2 quotes via the OTC Markets website.
  • This follows the March 2026 announcement of a transformative transaction with BAT DE Investments involving debt conversion and equity injection.
Material Impact
  • The OTCQX upgrade is a validation of the company's improved financial standing following the March 2026 BAT transaction which eliminated ~$65M in debt.
  • While positive for liquidity and institutional visibility, it does not fundamentally alter revenue streams or operational capacity compared to the prior financing news.
  • The market likely anticipated this upgrade given the balance sheet cleanup disclosed in Q4 2025 earnings; therefore, the immediate price impact is expected to be muted relative to the March announcement.
  • It confirms management's ability to meet higher governance standards post-restructuring, reducing regulatory risk perception for OTC investors.
CWEB · Price
Company Overview
  • Charlotte's Web is a leading hemp-derived CBD brand transitioning into pharmaceutical development via its subsidiary DeFloria.
  • Flagship Project: DeFloria AJA001 oral solution for irritability associated with autism spectrum disorder (ASD).
  • The company has received FDA clearance to proceed to Phase 2 trials, holding exclusive manufacturing rights and ~33% equity in DeFloria.
  • Operational focus includes internalization of Brightside gummy production (~75% in-house by 2026) and expansion into sleep-support categories (mushroom gummies, THC/CBN blends).
Read the original news release →

More from CHARLOTTE'S WEB HOLDINGS, INC.

Jun 26, 2026 · 07:22

Charlotte's Web Provides Update on Diverging Hemp Policies: Federal Momentum Builds as California Restricts Therapeutic Hemp Product Access

Production / Operations May 28, 2026 · 19:34

Charlotte's Web Closes BAT Deal, Eliminating Debt Overhang but Facing Dilution and Revenue Headwinds

Financings May 28, 2026 · 14:23

Charlotte's Web Secures BAT Partnership, But Dilution and Cash Burn Weigh on Sentiment

Financings May 13, 2026 · 07:08

Debt Relief Looms Over Revenue Decline as Liquidity Crunch Precedes Shareholder Vote

Earnings Mar 31, 2026 · 07:07

BAT Debt Swap and Medicare Pilot Buy Time as Cash Burn Persists

Earnings Mar 30, 2026 · 22:59

Charlotte’s Web Swaps $65M Debt for BAT’s 40% Stake as Medicare Pilot Kicks Off

Financings